COVID-19 and stroke: A review
Volume 2, Issue 2, June 2021, Pages 76-83
Hemorrhage in brain tumor – An unresolved issue
Volume 3, Issue 2, June 2022, Pages 98-102
The relationship between COVID-19 infection and intracranial hemorrhage: A systematic review
Volume 2, Issue 4, December 2021, Pages 141-150
Pituitary apoplexy following adenoviral vector-based COVID-19 vaccination
Volume 4, Issue 1, March 2023, Pages 27-29
Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine
Volume 2, Issue 4, December 2021, Pages 165-167
Inflammation in intracerebral hemorrhage: A bibliometric perspective
Volume 5, Issue 3, June 2024, Pages 107-116
Diabetes mellitus: A common comorbidity increasing hemorrhagic transformation after tPA thrombolytic therapy for ischemic stroke
Volume 2, Issue 3, September 2021, Pages 116-123
In vitro models of intracerebral hemorrhage
Volume 3, Issue 3, September 2022, Pages 105-107
Cerebral vasospasm after subarachnoid hemorrhage: Developing treatments
Volume 2, Issue 1, March 2021, Pages 15-23
Severe stroke in patients admitted to intensive care unit after COVID-19 infection: Pictorial essay of a case series
Volume 3, Issue 1, March 2022, Pages 29-35
Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage
Volume 5, Issue 2, April 2024, Pages 62-68
Vertebral artery dissecting aneurysm rupture under severe COVID-19
Volume 3, Issue 4, December 2022, Pages 210-213
Symptomatic peduncular, cavernous bleeding following SARS-CoV-2 vaccination induced immune thrombocytopenia
Volume 2, Issue 4, December 2021, Pages 169-171
Inflammatory response in sepsis and hemorrhagic stroke
Volume 4, Issue 2, June 2023, Pages 96-107
Advancement in the haemodynamic study of intracranial aneurysms by computational fluid dynamics
Volume 2, Issue 2, June 2021, Pages 71-75
Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells
Volume 4, Issue 3, September 2023, Pages 147-153
A translational perspective on intracranial pressure responses following intracerebral hemorrhage in animal models
Volume 2, Issue 1, March 2021, Pages 34-48
Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms
Volume 4, Issue 3, September 2023, Pages 154-173
MMP-2/9-cleaved occludin promotes endothelia cell death in ischemic stroke
Volume 2, Issue 2, June 2021, Pages 63-70
Fluid balance management with loop diuretics in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: A case series
Volume 5, Issue 2, April 2024, Pages 74-78
Increased plasma periostin concentration predicts angiographic vasospasm development in non-severe aneurysmal subarachnoid hemorrhage
Volume 5, Issue 1, February 2024, Pages 1-7
The role of mural cells in hemorrhage of brain arteriovenous malformation
Volume 2, Issue 1, March 2021, Pages 49-56
The role of crosstalk between cerebral immune cells and peripheral immune cells in the damage and protection of blood–brain barrier after intracerebral hemorrhage
Volume 5, Issue 3, June 2024, Pages 117-130
Poor grade subarachnoid hemorrhage: Treatment decisions and timing influence outcome. Should we, and when should we treat these patients?
Volume 2, Issue 1, March 2021, Pages 29-33
Evolving approaches in the management of patients with subarachnoid hemorrhage from 2002 to 2022: The impact of clazosentan and treatment modalities on outcomes
Volume 5, Issue 2, April 2024, Pages 55-61
Production and hosting by Elsevier on behalf of KeAi Communications Co. Ltd